Induction of disease remission with one cycle of alemtuzumab in relapsing-remitting MS. [electronic resource]
Producer: 20180920Description: 1226-1229 p. digitalISSN:- 1432-1459
- Adult
- Alemtuzumab -- adverse effects
- Disability Evaluation
- Disease Progression
- Female
- Follow-Up Studies
- Humans
- Immunologic Factors -- adverse effects
- Magnetic Resonance Imaging
- Male
- Multiple Sclerosis, Relapsing-Remitting -- diagnostic imaging
- Remission Induction
- Retrospective Studies
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.